87 results
425
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
24 Mar 22
Business combination disclosure
9:09am
) (a) words of any gender include each other gender and neuter form; (b) words using the singular or plural number also include the plural or singular … in this Agreement to any gender include references to all genders, and references to the singular include references to the plural and vice versa. Unless
8-K
EX-10.1
7qrudgjm1yd
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.2
oet7mpcta0jl61 eq8o
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.4
242sdif
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.1
9tl hsyajc8rph
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.1
qy3obbs2j3f4vowo so
13 Oct 20
Entry into a Material Definitive Agreement
8:44am
8-K
EX-10.4
otrji08
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.1
ys2wh
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.3
7xog29sd
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.2
32c7wkf7zgfa3r
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
SC TO-C
EX-2.1
qosjjf
10 Aug 20
Information about tender offer
9:50pm
8-K
EX-2.1
8vajqaft18h3vis1p
10 Aug 20
Tender and Support Agreement
9:48pm
DEFA14A
wg22cy76 5ccg0y
4 Jun 19
Additional proxy soliciting materials
5:07pm
8-K
EX-10.1
0dfzu pmpw
9 Aug 18
Entry into a Material Definitive Agreement
9:05am